RTP startup Entegrion launches sales of blood-loss dressing

Research Triangle Park, N.C. — RTP startup Entegrion, which is developing blood coagulation and related technologies, is launching commercial sales of its proprietary bandages that are designed to promote blood clotting.

The company, which utilizes technology developed at the University of North Carolina at Chapel Hill and East Carolina University, recently received Food and Drug Administration approval for one of its Stasilon, a bandage that promotes blood clotting.

The bandages will be sold by LC Industries, which is based in Durham.

Entegrion developed the technology in cooperation with the U.S. Office of Naval research.

The bandages come in 4-inch and 2-inch square sizes.